Trial Profile
The efficacy and mortality outcomes of Clopidogrel and ticagrelor in patients with acute coronary syndromes (ACS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms CATH SHAMI study
- 27 Dec 2016 New trial record
- 01 Nov 2016 Results published in the Journal of the American College of Cardiology